thyroxine has been researched along with Angioma in 12 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.
Excerpt | Relevance | Reference |
---|---|---|
"There have been reports of the use of levothyroxine or levothyroxine plus liothyronine for consumptive hypothyroidism caused by hepatic hemangiomas." | 7.85 | Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas. ( Hasegawa, Y; Higuchi, S; Takagi, M, 2017) |
" An association with hypothyroidism has been previously reported and is believed to be secondary to the conversion of thyroxine (fT4) to biologically inactive reverse triiodothyronine (rT3) by type 3 iodothyronine deiodinase (D3)." | 7.76 | Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy. ( Dattani, MT; Langham, S; Mullis, PE; Peters, C, 2010) |
"In consumptive hypothyroidism associated with infantile hepatic hemangiomas (IHH), elevated reverse triiodothyronine (rT3) is known due to elevated D3." | 4.12 | Advantages of monitoring rT3 and dividing LT3 dose in the treatment of consumptive hypothyroidism associated with infantile hepatic hemangioma. ( Igaki, J; Kina, Y; Koki, M; Matsuoka, T; Numazawa, M; Tomari, K, 2022) |
" The L-thyroxine replacement dose in patients with consumptive hypothyroidism is inappropriately higher than that in congenital hypothyroidism." | 3.88 | Severe consumptive hypothyroidism caused by multiple infantile hepatic haemangiomas. ( Demiral, M; Gundoğdu, E; Simsek, E, 2018) |
"There have been reports of the use of levothyroxine or levothyroxine plus liothyronine for consumptive hypothyroidism caused by hepatic hemangiomas." | 3.85 | Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas. ( Hasegawa, Y; Higuchi, S; Takagi, M, 2017) |
" An association with hypothyroidism has been previously reported and is believed to be secondary to the conversion of thyroxine (fT4) to biologically inactive reverse triiodothyronine (rT3) by type 3 iodothyronine deiodinase (D3)." | 3.76 | Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy. ( Dattani, MT; Langham, S; Mullis, PE; Peters, C, 2010) |
" This case emphasizes the importance of screening for hypothyroidism in patients with hemangiomas and the potential therapeutic benefit of prednisolone therapy in this condition." | 3.74 | Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas. ( Cho, YH; Hardwick, R; Howard, NJ; Howman-Giles, R; Lord, D; Mansour, A; Taplin, C, 2008) |
"Consumptive hypothyroidism is a rare paraneoplastic syndrome characterized by excessive inactivation of the thyroid hormones due to increased type 3 iodothyronine deiodinase activity of tumors." | 1.56 | A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas. ( Hong, KT; Kim, GB; Kim, YH; Ko, JS; Lee, YA; Lee, YJ; Shin, CH, 2020) |
"Consumptive hypothyroidism is a rare condition related to massive infantile hemangiomas producing an excess of the thyroid-hormone-inactivating enzyme type 3 iodothyronine deiodinase." | 1.38 | Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. ( Chiumello, G; Cortinovis, F; Di Frenna, M; Gelmetti, C; Passoni, A; Persani, L; Rabbiosi, S; Vigone, MC; Weber, G, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Numazawa, M | 1 |
Tomari, K | 1 |
Igaki, J | 1 |
Koki, M | 1 |
Kina, Y | 1 |
Matsuoka, T | 1 |
Kim, YH | 1 |
Lee, YA | 1 |
Shin, CH | 1 |
Hong, KT | 1 |
Kim, GB | 1 |
Ko, JS | 1 |
Lee, YJ | 1 |
Higuchi, S | 1 |
Takagi, M | 1 |
Hasegawa, Y | 1 |
Campbell, V | 1 |
Beckett, R | 1 |
Abid, N | 1 |
Hoey, S | 1 |
Simsek, E | 1 |
Demiral, M | 1 |
Gundoğdu, E | 1 |
Peters, C | 1 |
Langham, S | 1 |
Mullis, PE | 1 |
Dattani, MT | 1 |
Vigone, MC | 1 |
Cortinovis, F | 1 |
Rabbiosi, S | 1 |
Di Frenna, M | 1 |
Passoni, A | 1 |
Persani, L | 1 |
Chiumello, G | 1 |
Gelmetti, C | 1 |
Weber, G | 1 |
Huang, SA | 1 |
Mulcahey, MA | 1 |
Crescenzi, A | 1 |
Chung, M | 1 |
Kim, BW | 1 |
Barnes, C | 1 |
Kuijt, W | 1 |
Turano, H | 1 |
Harney, J | 1 |
Larsen, PR | 1 |
Meyer, EL | 1 |
Wagner, MS | 1 |
Maia, AL | 1 |
Cho, YH | 1 |
Taplin, C | 1 |
Mansour, A | 1 |
Howman-Giles, R | 1 |
Hardwick, R | 1 |
Lord, D | 1 |
Howard, NJ | 1 |
Schmid, L | 1 |
Lauer, O | 1 |
Bayer-Pietsch, E | 1 |
Steuer, G | 1 |
Pabst, HW | 1 |
Faglia, G | 1 |
Ferrari, C | 1 |
Neri, V | 1 |
Beck-Peccoz, P | 1 |
Ambrosi, B | 1 |
Valentini, F | 1 |
1 review available for thyroxine and Angioma
Article | Year |
---|---|
[Iodothyronine deiodinases expression in thyroid neoplasias].
Topics: Biomarkers, Tumor; Carcinoma, Papillary; Gene Expression Regulation, Enzymologic; Hemangioma; Humans | 2007 |
11 other studies available for thyroxine and Angioma
Article | Year |
---|---|
Advantages of monitoring rT3 and dividing LT3 dose in the treatment of consumptive hypothyroidism associated with infantile hepatic hemangioma.
Topics: Hemangioma; Humans; Hypothyroidism; Liver Neoplasms; Male; Thyroxine; Triiodothyronine; Triiodothyro | 2022 |
A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cholestasis; Drug Therapy, Combination; Heart | 2020 |
Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
Topics: Hemangioma; Hormone Replacement Therapy; Humans; Hypothyroidism; Infant; Liver; Liver Neoplasms; Mal | 2017 |
Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine
Topics: Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Hypothyroidism; Infant; Infant, Newborn; Li | 2018 |
Severe consumptive hypothyroidism caused by multiple infantile hepatic haemangiomas.
Topics: Congenital Hypothyroidism; Hemangioma; Humans; Infant; Liver Neoplasms; Male; Prognosis; Severity of | 2018 |
Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy.
Topics: Hemangioma; Humans; Hypothyroidism; Infant; Iodide Peroxidase; Liver Neoplasms; Male; Thyroxine; Tri | 2010 |
Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma.
Topics: Adrenal Cortex Hormones; Congenital Hypothyroidism; Female; Hemangioma; Humans; Hypothyroidism; Infa | 2012 |
Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase.
Topics: Epithelium; Estradiol; Fibroblasts; Hemangioma; Humans; Iodide Peroxidase; Muscle Cells; Muscle, Ske | 2005 |
Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas.
Topics: Developmental Disabilities; Glucocorticoids; Hemangioma; Humans; Hypothyroidism; Infant; Liver Neopl | 2008 |
[Lingual goiter with special regard to diagnosis and therapy].
Topics: Adenoma; Adult; Cysts; Diagnosis, Differential; Female; Goiter; Hemangioma; Humans; Iodine Radioisot | 1980 |
High plasma thyrotrophin levels in two patients with pituitary tumour.
Topics: 17-Hydroxycorticosteroids; Adenoma, Chromophobe; Adult; Biological Assay; Blood Pressure; Cerebral A | 1972 |